1 week ago
PepGen (PEPG) Stock Soars 146% After Positive Drug Trial Results
TLDR PepGen stock traded at $5.76 on Tuesday, up about 146%. The 10 mg/kg cohort showed 46.5% average splicing correction at week 13. No serious or severe adverse events were reported. An FDA partial clinical hold on the FREEDOM2 study is still in place. Cash of $104.8M should fund operations into 2028. PepGen (PEPG) stock [...]
The post PepGen (PEPG) Stock Soars 146% After Positive Drug Trial Results appeared first on Blockonomi.
Source: Blockonomi →Related News
- 28 minutes ago
Nvidia tops estimates, issues strong guidance; shares rise
- 29 minutes ago
Microsoft Corporation (MSFT) Stock: Fall 2.37% Despite Major AI Security Initia...
- 1 hour ago
KIDZ AI Inc. (KIDZ) Stock: Eyes Growth Through Synestria GPU Computing Partnersh...
- 1 hour ago
Vertiv Holdings (VRT) Stock: Expands 800 VDC Power Systems for AI Data Centers
- 2 hours ago
Coinbase CEO says AI agents will account for '99.9%' of transactions within a de...
